• Guidance on the prioritization of key populations for COVID-19 immunization
• Planning guidance for administration of COVID-19 vaccine
• Summary of National Advisory Committee on Immunization (NACI) statement: Recommendations on the …
• Guidance for market authorization requirements for COVID-19 vaccines: Rolling submissions, non-clinical and …
• Guidance on applications for COVID-19 drug clinical trials under the Regulations: Overview